Evidence map›Paper›PMID 33407891›Full record

ArticleJournal of intensive care2021

Occurrence and incidence rate of peripheral intravascular catheter-related phlebitis and complications in critically ill patients: a prospective cohort study (AMOR-VENUS study).

Hideto Yasuda, Ryohei Yamamoto, Yoshiro Hayashi, Yuki Kotani, Yuki Kishihara, Natsuki Kondo, Kosuke Sekine, Nobuaki Shime, Keita Morikane, Takayuki Abe and 23 more

Abstract read
In one paragraph

Article in Journal of intensive care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Development of a Machine Learning-Based Model for Predicting the Incidence of Peripheral Intravenous Catheter-Associated Phlebitis.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Hideto YasudaDepartment of Emergency and Critical Care Medicine, Jichi Medical University Saimata Medical Center, 1-847, Amanuma-cho, Oomiya-ku, Saitama-shi, Saitama, 330-8503, Japan. yasudahideto@me.com.ORCID http://orcid.org/0000-0003-3153-1595
Ryohei YamamotoDepartment of Intensive Care Medicine, Kameda Medical Center, Chiba, Japan.
Yoshiro HayashiDepartment of Intensive Care Medicine, Kameda Medical Center, Chiba, Japan.
Yuki KotaniDepartment of Intensive Care Medicine, Kameda Medical Center, Chiba, Japan.
Yuki KishiharaEmergency and Critical Care Medicine, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
Natsuki KondoDepartment of Intensive Care Medicine, Kameda Medical Center, Chiba, Japan.
Kosuke SekineDepartment of Medical Engineer, Kameda Medical Center, Chiba, Japan.
Nobuaki ShimeDepartment of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Keita MorikaneDivision of Clinical Laboratory and Infection Control, Yamagata University Hospital, Yamagata, Japan.
Takayuki AbeBiostatistics, Clinical and Translational Research Center, Keio University School of Medicine, Tokyo, Japan.
Toru TakebayashiDepartment of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.
Mikihiro MaedaDepartment of Pharmacy, St. Marianna University Hospital, Kanagawa, Japan.
Takuya ShigaIntensive Care Unit, Tohoku University Hospital, Miyagi, Japan.
Taku FurukawaDepartment of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Mototaka InabaDepartment of Emergency and Critical Care Medicine, Okayama Saiseikai General Hospital, Okayama, Japan.
Sachito FukudaIntensive Care Unit, Mitsui Memorial Hospital, Tokyo, Japan.
Kiyoyasu KurahashiDepartment of Anesthesiology and Intensive Care Medicine, International University of Health and Welfare, School of Medicine, Chiba, Japan.
Sarah MurakamiIntensive Care Unit, Sakai city medical center, Osaka, Japan.
Yusuke YasumotoEmergency And Critical Care Medicine, Nerima Hikarigaoka Hospital, Tokyo, Japan.
Tetsuro KamoDivision of Critical Care Medicine, Saiseikai Utsunomiya Hospital, Tochigi, Japan.
Masaaki SakurayaDepartment of Emergency and Intensive Care Medicine, JA Hiroshima General Hospital, Hiroshima, Japan.
Rintaro YanoDivision of Intensive Care Unit, Nagasaki University Hospital, Nagasaki, Japan.
Toru HifumiEmergency Medical Center, Kagawa University Hospital, Kagawa, Japan.
Masahito HoriguchiDivision of Emergency Medicine, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Izumi NakayamaIntensive Care Unit, Okinawa Chubu Hospital, Okinawa, Japan.
Masaki NakaneCritical Care Center, Yamagata University Hospital, Yamagata, Japan.
Kohei OtaDepartment of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Tomoaki YatabeIntensive Care Unit, Kochi Medical School Hospital, Kochi, Japan.
Masataka YoshidaIntensive Care Unit, Shiroyama Hospital, Osaka, Japan.
Maki MurataDepartment of Acute Care and General Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan.
Kenichiro FujiiEmergency Intensive Care Unit, Fujita Health University, Nagoya, Japan.
Junki IshiiDepartment of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
AMOR-VENUS study group

Funding

Grants-in-Aid for Scientific Research, Japan Society For The Promotion Of Science 17K15870
6 · The paper itself

Abstract

backgroundThe lack of precise information on the epidemiology of peripheral intravascular catheter (PIVC)-related phlebitis and complications in critically ill patients results in the absence of appropriate preventive measures. Therefore, we aimed to describe the epidemiology of the use of PIVCs and the incidence/occurrence of phlebitis and complications in the intensive care unit (ICU).

methodsThis prospective multicenter cohort study was conducted in 23 ICUs in Japan. All consecutive patients aged ≥ 18 years admitted to the ICU were enrolled. PIVCs inserted prior to ICU admission and those newly inserted after ICU admission were included in the analysis. Characteristics of the ICU, patients, and PIVCs were recorded. The primary and secondary outcomes were the occurrence and incidence rate of PIVC-related phlebitis and complications (catheter-related blood stream infection [CRBSI] and catheter failure) during the ICU stay.

resultsWe included 2741 patients and 7118 PIVCs, of which 48.2% were inserted in the ICU. PIVC-related phlebitis occurred in 7.5% (95% confidence interval [CI] 6.9-8.2%) of catheters (3.3 cases / 100 catheter-days) and 12.9% (95% CI 11.7-14.2%) of patients (6.3 cases / 100 catheter-days). Most PIVCs were removed immediately after diagnosis of phlebitis (71.9%). Grade 1 was the most common phlebitis (72.6%), while grade 4 was the least common (1.5%). The incidence rate of CRBSI was 0.8% (95% CI 0.4-1.2%). In cases of catheter failure, the proportion and incidence rate per 100 intravenous catheter-days of catheter failure were 21% (95% CI 20.0-21.9%) and 9.1 (95% CI 8.7-10.0), respectively.

conclusionPIVC-related phlebitis and complications were common in critically ill patients. The results suggest the importance of preventing PIVC-related complications, even in critically ill patients.

trial registrationUMIN-CTR, the Japanese clinical trial registry (registration number: UMIN000028019 , July 1, 2017).

Indexed as

CatheterCatheter-Related InfectionsCritically ill patientEpidemiologyIntensive care unitPhlebitis

Identifiers

PMID33407891
PMCPMC7789473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.